Trials / Completed
CompletedNCT03030625
VMAT for Dominant Intraprostatic Lesion
Dose Intensification With a Focal Boost to Dominant Intraprostatic Lesion Using Volumetric Modulated Arc Therapy /Image Guided Radiotherapy in Patients With Localized Prostate Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Fundación de Investigación Biomédica - Hospital Universitario de La Princesa · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to determine the efficacy and safety of the implementation of a program of " image-guided focal Intensification dose to intraprostatic dominant lesion " in men with localized prostate cancer (PCa) of intermediate and high risk (criteria NCCN) eligible to receive radiotherapy in the Department of Radiation Oncology of HUP (Hospital Universitario de La Princesa), within the established dose escalation protocol with intensity modulated image-guided radiotherapy (IMRT / IGRT).
Detailed description
The aim of this study was to determine the efficacy and safety of the implementation of a program of " image-guided focal Intensification dose to intraprostatic dominant lesion " in men with localized prostate cancer (PCa) of intermediate and high risk (criteria NCCN) eligible to receive radiotherapy in the Department of Radiation Oncology of HUP (Hospital Universitario de La Princesa), within the established dose escalation protocol with intensity modulated image-guided radiotherapy (IMRT / IGRT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | IGRT/VMAT focal therapy boost to DIL | Image-guided/VMAT focal Intensification dose to intraprostatic dominant lesion in men with localized prostate cancer (PCa) of intermediate and high risk (criteria NCCN) eligible to receive radiotherapy |
Timeline
- Start date
- 2017-03-13
- Primary completion
- 2023-01-25
- Completion
- 2023-01-25
- First posted
- 2017-01-25
- Last updated
- 2024-07-03
- Results posted
- 2023-05-24
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03030625. Inclusion in this directory is not an endorsement.